Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia
暂无分享,去创建一个
Pu Zhang | Susanne Schnittger | D. Tenen | G. Behre | S. Schnittger | T. Pabst | H. Radomska | Pu Zhang | B. Mueller | Thomas Pabst | S. Narravula | W. Hiddemann | Hanna S. Radomska | Beatrice U. Mueller | Sailaja Narravula | Gerhard Behre | Wolfgang Hiddemann | Daniel G. Tenen | Hanna S. Radomska | Daniel G. Tenen
[1] C. Calkhoven,et al. Translation start site multiplicity of the CCAAT/enhancer binding protein alpha mRNA is dictated by a small 5' open reading frame. , 1994, Nucleic acids research.
[2] L. Wolff. Contribution of oncogenes and tumor suppressor genes to myeloid leukemia. , 1997, Biochimica et biophysica acta.
[3] K. Johnson. An Update. , 1984, Journal of food protection.
[4] S. McKnight,et al. The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. , 1988, Science.
[5] T. Rabbitts,et al. Chromosomal translocations in human cancer , 1994, Nature.
[6] S. McKnight,et al. Identification of two polypeptide segments of CCAAT/enhancer-binding protein required for transcriptional activation of the serum albumin gene. , 1990, Genes & development.
[7] D. Tenen,et al. Optimization of transient transfection into human myeloid cell lines using a luciferase reporter gene. , 1991, Experimental hematology.
[8] D. Tenen,et al. PU.1 (Spi-1) and C/EBP alpha regulate the granulocyte colony-stimulating factor receptor promoter in myeloid cells. , 1996, Blood.
[9] M. Kozak. The scanning model for translation: an update , 1989, The Journal of cell biology.
[10] D. Tenen,et al. CCAAT/Enhancer Binding Protein α Is a Regulatory Switch Sufficient for Induction of Granulocytic Development from Bipotential Myeloid Progenitors , 1998, Molecular and Cellular Biology.
[11] J. P. Condreay,et al. Impaired proliferation and tumorigenicity induced by CCAAT/enhancer-binding protein. , 1996, Cancer research.
[12] M. Lane,et al. CCAAT/enhancer binding protein alpha is sufficient to initiate the 3T3-L1 adipocyte differentiation program. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[13] R. Umek,et al. CCAAT-enhancer binding protein: a component of a differentiation switch. , 1991, Science.
[14] S. McKnight,et al. Isolation of a recombinant copy of the gene encoding C/EBP. , 1988, Genes & development.
[15] J. R. Smith,et al. CCAAT/enhancer-binding protein alpha (C/EBP alpha) inhibits cell proliferation through the p21 (WAF-1/CIP-1/SDI-1) protein. , 1996, Genes & development.
[16] E. Ziff,et al. Three levels of functional interaction determine the activity of CCAAT/enhancer binding protein-alpha on the serum albumin promoter. , 1994, Genes & development.
[17] U. Schibler,et al. CCAAT/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Licht,et al. Transcription factors, normal myeloid development, and leukemia. , 1997, Blood.
[19] D. Tenen,et al. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[20] P.,et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT y enhancer binding protein « -deficient mice , 1997 .
[21] B. Trask,et al. The CCAAT/enhancer binding protein (C/EBPα) gene (CEBPA) maps to human chromosome 19q13.1 and the related nuclear factor NF-IL6 (C/EBPβ) gene (CEBPB) maps to human chromosome 20q13.1 , 1992 .
[22] R. Umek,et al. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. , 1991, Genes & development.
[23] J. Schalkwijk,et al. Transcription Factor C/EBPα: Novel Sites of Expression and Cloning of the Human Gene , 1997, Biological chemistry.
[24] C. Barlow,et al. Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[25] H. Yamasaki,et al. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. , 1999, Blood.
[26] U. Schibler,et al. A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the sam mRNA , 1991, Cell.
[27] 大里 元美. Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2 α B gene associated with myeloblastic leukemias , 1999 .
[28] A. Chumakov,et al. C/EBP-ε: Chromosomal mapping and mutational analysis of the gene in leukemia and preleukemia , 1997 .
[29] J. Downing,et al. The t(8;21) Fusion Product, AML-1–ETO, Associates with C/EBP-α, Inhibits C/EBP-α-Dependent Transcription, and Blocks Granulocytic Differentiation , 1998, Molecular and Cellular Biology.
[30] C. Hsieh,et al. Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide-mediated acute-phase response , 1996, Molecular and cellular biology.
[31] G. Darlington,et al. Inhibition of cell proliferation by C/EBPα occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen , 1995 .
[32] O. MacDougald,et al. A 30-kDa alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Lekstrom‐Himes,et al. CCAAT/Enhancer Binding Protein ɛ Is Critical for Effective Neutrophil-Mediated Response to Inflammatory Challenge , 1999 .
[34] Steven M. Holland,et al. Neutrophil-specific Granule Deficiency Results from a Novel Mutation with Loss of Function of the Transcription Factor CCAAT/Enhancer Binding Protein ε , 1999, The Journal of experimental medicine.